Here, we reported structural activity relationship studies (SAR) leading to the identification of MMRi71 as an inhibitor of the E3 ligase activity of MDM2-MDM4, an inducer of MDM4 and FTH1 dual protein degradation and p53-independent apoptosis in leukemia cells. Here, MDM4 is linked to leukemia.